0

The full content of Annals is available to subscribers

Subscribe/Learn More  >
Articles |

Increased Risk for Venous Thrombosis in Carriers of the Prothrombin G→A20210 Gene Variant

Maurizio Margaglione, MD; Vincenzo Brancaccio, MD; Nicola Giuliani, MD; Giovanna D'Andrea, BS; Giuseppe Cappucci, BS; Luigi Iannaccone, BS; Gennaro Vecchione, BS; Elvira Grandone, MD; and Giovanni Di Minno, MD
[+] Article and Author Information

From IRCCS, Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy; Ospedale A. Cardarelli, Napoli, Italy; and Universita di Palermo, Palermo, Italy. Requests for Reprints: Maurizio Margaglione, MD, Unita di Aterosclerosi e Trombosi, IRCCS, Casa Sollievo della Sofferenza, viale Cappuccini, San Giovanni Rotondo (FG) 71013, Italy. Current Author Addresses: Drs. Margaglione, Giuliani, and Grandone and Mrs. D'Andrea, Mr. Cappucci, and Mr. Vecchione: Unita di Aterosclerosi e Trombosi, IRCCS, Casa Sollievo della Sofferenza, viale Cappuccini, San Giovanni Rotondo (FG) 71013, Italy.


Copyright ©2004 by the American College of Physicians


Ann Intern Med. 1998;129(2):89-93. doi:10.7326/0003-4819-129-2-199807150-00003
Text Size: A A A

Background: A mutation in the prothrombin gene (G→A20210) has been associated with higher plasma prothrombin levels and an increased tendency for venous thrombosis.

Objective: To determine whether the prothrombin A20210 allele is independently associated with the occurrence of venous thrombosis.

Design: Case-control study.

Setting: Two thrombosis centers in southern Italy.

Patients: 281 consecutive patients with venous thrombosis confirmed by objective tests and 850 controls.

Measurements: Medical history was collected on standardized questionnaires. The presence of prothrombin G→A20210 and factor V Leiden mutations was determined by polymerase chain reaction. The presence of anticoagulant factors and prothrombin activity was determined by tests of function.

Results: In 150 controls, increased prothrombin activity (P < 0.001) was associated with the prothrombin A20210 allele. This allele was more frequent in patients than in controls (8.01% compared with 2.29%; P < 0.001) and was associated with an increased risk for thrombosis (odds ratio, 3.88 [95% CI, 2.23 to 6.74]). The increased prevalence of this allele was independent of the presence of the factor V Leiden mutation. After adjustment for sex, age, arterial thrombosis, and factor V Leiden mutation, the risk was still significantly elevated (odds ratio, 3.13 [CI, 1.89 to 5.21]). Moreover, the overall prevalence of inherited coagulation abnormalities was significantly higher in patients with thrombosis of the lower extremities than in patients with thrombosis of the upper extremities (odds ratio, 3.77 [CI, 1.10 to 12.93]). Fourteen patients carried both the prothrombin G→A20210 and factor V Leiden mutations.

Conclusions: The prothrombin A20210 allele is independently associated with the occurrence of venous thrombosis, particularly in patients with a history of thrombosis of the lower extremities.

Figures

Tables

References

Letters

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Comments

Submit a Comment
Submit a Comment

Summary for Patients

Clinical Slide Sets

Terms of Use

The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.

Toolkit

Buy Now

to gain full access to the content and tools.

Want to Subscribe?

Learn more about subscription options

Advertisement
Related Articles
Journal Club
Related Point of Care
Topic Collections
PubMed Articles
Forgot your password?
Enter your username and email address. We'll send you a reminder to the email address on record.
(Required)
(Required)